Point-of-care testing during medical emergency team activations: A pilot study

被引:8
作者
Calzavaccaa, P. [1 ,2 ]
Licari, E. [1 ,2 ]
Tee, A. [1 ,2 ]
Bellomo, R. [1 ,2 ]
机构
[1] Austin Hosp, Dept Intens Care, Melbourne, Vic 3084, Australia
[2] Austin Hosp, Dept Med, Melbourne, Vic 3084, Australia
关键词
Medical emergency team; Rapid response system; Critical illness; D dimer; Brain natriuretic peptide; Myoglobin; Creatinine kinase; Troponin I; Mortality; CRITICALLY-ILL PATIENTS; DISSEMINATED INTRAVASCULAR COAGULATION; INTENSIVE-CARE; NATRIURETIC PEPTIDE; D-DIMER; HEART-FAILURE; PULMONARY-DISEASE; VENOUS THROMBOEMBOLISM; MYOCARDIAL-INFARCTION; CONSENSUS CONFERENCE;
D O I
10.1016/j.resuscitation.2012.02.012
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To estimate the prognostic value of point-of-care measurement of biomarkers related to dyspnea in patients receiving a medical emergency team (MET) review. Design: Prospective observational study. Setting: University affiliated hospital. Patients: Cohort of 95 patients receiving MET review over a six month period. Methods: We used a commercial multi-biomarker panel for shortness-of-breath (SOB panel) (Biosite Triage Profiler, Biosite Incorporated (R), 9975 Summers Ridge Road, San Diego, CA 92121, USA) including Brain natriuretic peptide (BNP), D-dimer, myoglobin (Myo), creatine kinase MB isoenzyme (CK-MB) and troponin I (Tn-I). We recorded information about demographics, MET review triggers, and MET procedures and patient outcome. Results: Mean age was 70.5 (+/- 15) years, 38 (41%) patients had a history of chronic heart failure (CHF) and 67 (70%) chronic kidney disease (CKD). At MET activation, 42 (44%) patients were dyspneic. The multi-biomarker panel was positive for at least one marker in 48 (51%) cases. BNP and D-dimer had a sensitivity of 0.79 and 0.93 for ICU admission with a negative predictive value (NPV) of 0.89 and 0.92 respectively. Thirty-five (37%) patients died. BNP was positive in 85% of such cases with sensitivity and NPV of 0.86 and 0.82, respectively. D-dimer was positive in 77% of non-survivors with a sensitivity and NPV of 0.94 and 0.88, respectively. BNP (area under the curve of receiver operating characteristic curve -AUC-ROC: 0.638) and D-dimer (AUC-ROC: 0.574) achieved poor discrimination of subsequent death. Similar findings applied to ICU admission. The combination of normal BNP and D-dimer levels completely ruled out ICU admission or death. The cardiac part of the panel was not useful in predicting ICU admission or mortality. Conclusions: Although, BNP and D-dimer are poor discriminants of ICU admission and hospital mortality, normal BNP and D-dimer levels practically exclude subsequent need for ICU admission and hospital mortality. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1119 / 1123
页数:5
相关论文
共 50 条
  • [41] Perspectives on Cost and Outcomes for Point-of-Care Testing
    Lee-Lewandrowski, Elizabeth
    Lewandrowski, Kent
    CLINICS IN LABORATORY MEDICINE, 2009, 29 (03) : 479 - +
  • [42] The clinical impact and prevalence of emergency point-of-care ultrasound: A prospective multicenter study
    Bobbia, Xavier
    Zieleskiewicz, Laurent
    Pradeilles, Christophe
    Hudson, Chloe
    Muller, Laurent
    Claret, Pierre Geraud
    Leone, Marc
    de la Coussaye, Jean-Emmanuel
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2017, 36 (06) : 383 - 389
  • [43] Prognostic Factors in Emergency Department Patients with Glyphosate Surfactant Intoxication: Point-of-Care Lactate Testing
    Kim, Yong Hwan
    Lee, Jun Ho
    Cho, Kwang Won
    Lee, Dong Woo
    Kang, Mun Ju
    Lee, Kyoung Yul
    Lee, Young Hwan
    Hwang, Seong Youn
    Lee, Na Kyoung
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 (06) : 604 - 610
  • [44] The role of the medical emergency team in end-of-life care: A multicenter, prospective, observational study
    Jones, Daryl A.
    Bagshaw, Sean M.
    Barrett, Jonathon
    Bellomo, Rinaldo
    Bhatia, Gaurav
    Bucknall, Tracey K.
    Casamento, Andrew J.
    Duke, Graeme J.
    Gibney, Noel
    Hart, Graeme K.
    Hillman, Ken M.
    Jaederling, Gabriella
    Parmar, Ambica
    Parr, Michael J.
    CRITICAL CARE MEDICINE, 2012, 40 (01) : 98 - 103
  • [45] Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial
    Tomonaga, Yuki
    Gutzwiller, Felix
    Luescher, Thomas F.
    Riesen, Walter F.
    Hug, Markus
    Diemand, Albert
    Schwenkglenks, Matthias
    Szucs, Thomas D.
    BMC FAMILY PRACTICE, 2011, 12
  • [46] The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study
    Lenihan, Daniel J.
    Stevens, Patrick L.
    Massey, Mona
    Plana, Juan Carlos
    Araujo, Dejka M.
    Fanale, Michelle A.
    Fayad, Luis E.
    Fisch, Michael J.
    Yeh, Edward T. H.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (06) : 433 - 438
  • [47] Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing?
    Azzazy, HME
    Christenson, RH
    CLINICAL BIOCHEMISTRY, 2002, 35 (01) : 13 - 27
  • [48] Evaluation of point-of-care maternal venous lactate testing in normal pregnancy
    Maguire, Patrick J.
    Finlay, Janna
    Power, Karen A.
    Harley, Ruth
    Mhurchu, Muireann Ni
    Sheehan, Sharon R.
    Fanning, Rebecca A.
    Turner, Michael J.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2016, 29 (16) : 2607 - 2610
  • [49] The evaluation of point-of-care testing for determining hemoglobin levels in geriatric intensive care patients
    Honca, Tevfik
    Honca, Mehtap
    JOURNAL OF LABORATORY MEDICINE, 2018, 42 (05) : 189 - 193
  • [50] Role of Point-of-Care Ultrasound in Emergency Airway Management Outside the Operating Room
    Khorsand, Sarah
    Chin, Jeanette
    Rice, Jake
    Bughrara, Nibras
    Myatra, Sheila N.
    Karamchandani, Kunal
    ANESTHESIA AND ANALGESIA, 2023, 137 (01) : 124 - 136